Inhibition of HIV-1 replication by an improved hairpin ribozyme that includes an RNA decoy

RNA Biology

Volumn 2, Issue 2, 2005, Pages 75-79

  Barroso delJesus, Alicia ^a   Puerta Fernández, Elena ^a,c   Tapia, Natalia ^b   Romero López, Cristina ^a   Sánchez Luque, Francisco José ^a   Martínez, Miguel Angel ^b   Berzal Herranz, Alfredo ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c YALE UNIVERSITY   (United States)

Author keywords

AntiHIV 1 RNAs; Catalytic RNAs; Hairpin ribozyme; HIV 1 inhibition; RNA decoys; TAR decoy

Indexed keywords

ANTIGEN P24; RIBOZYME; TRANSACTIVATOR PROTEIN; VIRUS RNA;

ARTICLE; CATALYSIS; CATALYST; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; VIRUS INHIBITION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 25444478896     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.2.2.2044     Document Type: Article

References (32)

1. Muotri AR, da Veiga Pereira L, dos Reis Vasques L, Menck CF. Ribozymes and the antigene therapy: how a catalytic RNA can be used to inhibit gene function. Gene 1999; 237:303-10.
2. Puerta-Fernández E, Romero-López C, Barroso-delJesus A, Berzal-Herranz A. Ribozymes: recent advances in the development of RNA tools. FEMS Microbiol Rev 2003; 27:75-97.
3. Long DM, Uhlenbeck OC. Self-cleaving catalytic RNA. FASEB J 1993; 7:25-30.
4. White RR, Sullenger BA, Rusconi CP. Developing aptamers into therapeutics. J Clinic Inv 2000; 106:929-34.
5. Rimmele M. Nucleic acid aptamers as tools and drugs: recent developments. ChemBioChem 2003; 4:963-71.
6. Li MJ, Bauer G, Michienzi A, Yee JK, Lee NS, Kim J, Li S, Castanotto D, Zaia J, Rossi JJ. Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs. Mol Ther 2003; 8:196.
7. Burke JM. The Hairpin Ribozyme. Nucleic Acids Mol Biol 1994; 8:105-18.
8. Fedor MJ. Structure and function of the hairpin ribozyme. J Mol Biol 2000; 297:269-91.
9. Sargueil B, Pecchia DB, Burke JM. An improved version of the hairpin ribozyme functions as a ribonucleoprotein complex. Biochemistry 1995; 34:7739.
10. Barroso-delJesus A, Tabler M, Berzal-Herranz A. Comparative kinetic analysis of structural variants of the hairpin ribozyme reveals further potential to optimize its catalytic performance. Antisense Nucleic Acid Drug Dev 1999; 9:433-40.
11. Muessing MA, Smith DH, Capon DJ. Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell 1987; 48:691-701.
12. Arya SK, Guo C, Josephs SF, Wong-Staal F. Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). Science 1985; 229:69-73.
13. Cullen BR. Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism. Cell 1986; 46:973-82.
14. Feng S, Holland EC. HIV-1 tat trans-activation requires the loop sequence within TAR. Nature 1988; 334:165-7.
15. Lee SW, Gallardo HF, Gaspar O, Smith C, Gilboa E. Inhibition of HIV-1 in CEM cells by a potent TAR decoy. Gene Ther 1995; 2:377-84.
16. Smith C, Lee SW, Wong E, Gallardo H, Page K, Gaspar O, Lebkowski J, Gilboa E. Transient protection of human T-cells from human immunodeficiency virus type 1 infection by transduction with adeno-associated viral vectors which express RNA decoys Antiviral Res 1996; 32:99-115.
17. Yamamoto R, Koseki S, Ohkawa J, Murakami K, Nishikawa S, Taira K, Kumar PK. Inhibition of transcription by the TAR RNA of HIV-1 in a nuclear extract of HeLa cells. Nucleic Acids Res 1997; 25:3445-50.
18. Browning CM, Cagnon L, Good PD, Rossi JJ, Engelke DR, Markovitz DM. Potent inhibition of human immunodeficiency virus type 1 (HIV-1) gene expression and virus production by an HIV-2 tat activation-response RNA decoy. J Virol 1999; 73:5191-5.
19. Macpherson JL, Ely JA, Sun LQ, Symonds GP. Ribozymes in gene therapy of HIV-1. Front Biosci 1999; 4:497-505.
20. Sun LQ, Wang L, Gerlach WL, Symonds G. Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA. Nucleic Acids Res 1995; 23:2909-13.
21. Sun LQ, Pyati J, Smythe J, Wang L, Macpherson J, Gerlach WL, Symonds G. Resistance to human immunodeficiency virus type 1 infection conferred by transduction of human peripheral blood lymphocytes with ribozyme, antisense, or polymeric trans-activation response element constructs. Proc Natl Acad Sci USA 1995; 92:7272-6.
22. Pérez-Ruiz M, Barroso-delJesus A, Berzal-Herranz A. Specificity of the hairpin ribozyme. Sequence requirements surrounding the cleavage site. J Biol Chem 1999; 274:29376-80.
23. Puerta-Fernández E, Barroso-delJesus A, Romero-López C, Tapia N, Martínez MA, Berzal-Herranz A. Inhibition of HIV-1 replication by RNA targeted against the LTR region. AIDS 2005; 19:863-70.
24. Martínez MA, Gutiérrez A, Armand-Ugon M, Blanco J, Parera M, Gómez J, Clotet B, Este JA. Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication. AIDS 2002; 16:2385-90.
25. Berzal-Herranz A, Joseph S, Chowrira BM, Butcher SE, Burke JM. Essential nucleotide sequences and secondary structure elements of the hairpin ribozyme. EMBO 1993; 12:2567-73.
26. Ratner L, Haseltine W, Patarca R, Livak KJ, Starcich B, Josephs SF, et al. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 1985; 313:277-84.
27. Bohjanen PR, Colvin RA, Puttaraju M, Been MD, Garcia-Blanco MA. A small circular TAR RNA decoy specifically inhibits Tat-activated HIV-1 transcription. Nucleic Acids Res 1996; 24:3733-8.
28. Bohjanen PR, Liu Y, Garcia-Blanco MA. TAR RNA decoys inhibit tat-activated HIV-1 transcription after preinitiation complex formation. Nucleic Acids Res 1997; 25:4481-6.
29. Kawasaki H, Taira K. Identification of genes by hybrid ribozymes that couple cleavage activity with the unwinding activity of an endogenous RNA helicase. EMBO Rep 2002; 3:443-50.
30. Berkhout B. Structure and function of the human immunodeficiency virus leader RNA. Prog Nucleic Acid Res Mol Biol 1996; 54:1-34.
31. Berkhout B. Multiple biological roles associated with the repeat (R) region of the HIV-1 RNA genome. Adv Pharmacol 2000; 48:29-73.
32. Barroso-delJesus A, Berzal-Herranz A. Selection of targets and the most efficient hairpin ribozymes for inactivation of mRNAs using a self-cleaving RNA library. EMBO Rep 2001; 2:1112-8.